Canada Invests $23.8 Million in Quebec Radiopharmaceutical Plant, Supporting 225 Jobs
In Kirkland, Quebec, Canada, Industry Minister Mélanie Joly announced on October 8 a $23.8-million federal investment from the Strategic Response Fund in Jubilant Radiopharma Inc., supporting the modernization and expansion of its Kirkland radiopharmaceutical plant. The total project is valued at $94.5 million.
Once expanded, the facility will serve as a global centre of excellence for radiopharmaceutical production and research. These medicines are used in diagnostic imaging and treatment for diseases such as cancer, and their supply depends on short-lived isotope production, making domestic capacity directly relevant to Canada's health system.
The project will create and maintain 225 jobs and provide 35 paid student co-op placements. Jubilant Radiopharma is part of India's Jubilant Pharmova group, and the Kirkland plant is a key North American production site for the group.
Innovation, Science and Economic Development Canada says Ottawa has invested more than $2.5 billion since 2020 across 43 biomanufacturing, vaccine and therapeutics projects, and this investment continues that build-out.
Source: Innovation, Science and Economic Development Canada
Published by GSM · USA (original Chinese edition)
Photo: 正电子发射断层扫描（PET）设备，放射性药物用于此类诊断成像。/ A PET scanner; radiopharmaceuticals are used in this kind of diagnostic imaging. (Photo: Agentschap Zorg en Gezondheid, CC BY 3.0, via Wikimedia Commons)
